Cer

Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance1

Retrieved on: 
星期四, 八月 5, 2021
Biotechnology, Pharmaceutical, Health, Iron-deficiency anemia, Growth, United States dollar, Manuscript, ANCA, Board, Annual, Marketing, Scd, Income, Hospital, Kidney, Blood, Earnings before interest, taxes, depreciation and amortization, Erythropoiesis-stimulating agent, Review, European Medicines Agency, EMA, Cer, Food and Drug Administration, The New England Journal of Medicine, Sickle cell disease, Therapy, Group, CKD, Anemia, Population, Iron, Mortality, Advisory Committee, European Heart Journal, Depreciation, Dialysis, Raasi, Vifor Pharma, File, Quality of life, Leadership, Hyperkalemia, Awareness, European Space Agency, Pharma, Heart failure, Prescription Drug User Fee Act, Adoption, Annual general meeting, Maa, Executive Committee, Patient, COVID-19, PBM, CHF, NDA, Director, Overalls, Heart, Pharmaceutical industry, Medical device, Aquaculture

Based on the solid results in H1 2021, the Group is confident of achieving its full year guidance.

Key Points: 
  • Based on the solid results in H1 2021, the Group is confident of achieving its full year guidance.
  • Ferinject / Injectafer net sales increased 22.4% (up 22.8% at CER) to CHF 320.5 million in H1 2021 from CHF 261.9 million a year earlier.
  • As a result, Vifor Pharma posted net sales of CHF 73.7 million, up 1.4% or 8.5% at CER.
  • Abbas Hussain was appointed Chief Executive Officer of Vifor Pharma, succeeding Stefan Schulze, who has decided to step down for personal reasons.

LotLinx to Support LaFontaine Automotive Group's Mission for a Cancer Free World

Retrieved on: 
星期五, 五月 28, 2021
Cer, Vive, CER computers, Mihajlo Pupin Institute

The LotLinx team plans to join the automotive group at the foundation's first event of the year, U CAN-CER VIVE Evening for the Cure, on June 4th in Pontiac, MI.

Key Points: 
  • The LotLinx team plans to join the automotive group at the foundation's first event of the year, U CAN-CER VIVE Evening for the Cure, on June 4th in Pontiac, MI.
  • "On behalf of the passionate team at U CAN-CER VIVE, we greatly appreciate the support from LotLinx," said Kelley LaFontaine, co-founder, U CAN-CER VIVE.
  • "Their donation will go directly toward needed cancer research and ultimately get us closer to our mission of a cancer free world."
  • About LotLinx: Founded in 2012 and based out of Peterborough, NH, LotLinx is the automotive industry's leading inventory management and retailing technologies platform.

Canada Energy Regulator issues monetary penalty to Trans-Northern Pipelines Inc.

Retrieved on: 
星期四, 五月 6, 2021
Administrative Monetary Penalty, Punishments, Cer

b'CALGARY, Alberta, May 06, 2021 (GLOBE NEWSWIRE) -- Today the Canada Energy Regulator (CER) released full details of its $40,000 Administrative Monetary Penalty to Trans-Northern Pipelines Inc. (TNPI), the maximum amount based on the facts of this case.

Key Points: 
  • b'CALGARY, Alberta, May 06, 2021 (GLOBE NEWSWIRE) -- Today the Canada Energy Regulator (CER) released full details of its $40,000 Administrative Monetary Penalty to Trans-Northern Pipelines Inc. (TNPI), the maximum amount based on the facts of this case.
  • The company had received multiple notices of non-compliances and enforcement actions related to contaminated sites, and issuing this fine was the next step in our effort to bring the company into compliance.
  • The company completed the required testing and was given permission to resume work on June 3, 2019.
  • The CER is currently reviewing the company\xe2\x80\x99s plan and awaiting the results of the test.

QIAGEN Beats Outlook for Fourth Quarter and Full-Year 2020, Reaffirms Expectations for Further Growth in 2021

Retrieved on: 
星期二, 二月 9, 2021
Science, Biotechnology, Research, Medical Supplies, Oncology, Health, Medical devices, Infectious diseases, Medical software, Qiagen, Cer, Companies

Net sales in the fourth quarter of 2020 rose 38% (+36% at constant exchange rates, CER) to $571.2 million, and faster than the outlook for at least 32% CER growth.

Key Points: 
  • Net sales in the fourth quarter of 2020 rose 38% (+36% at constant exchange rates, CER) to $571.2 million, and faster than the outlook for at least 32% CER growth.
  • Adjusted earnings per share (EPS) grew 42% to $0.68 ($0.68 CER) against the outlook for about $0.64-0.65 CER.
  • Net sales for full-year 2020 increased 23% (+23% CER) to $1.87 billion, and exceeded the outlook for about 22% CER sales growth.
  • QIAGEN is committed to remaining at the forefront of the fight against COVID while expanding our business for post-pandemic growth.

ESI Group: Third-quarter 2020 Sales

Retrieved on: 
星期二, 十月 27, 2020
Manufacturing, Data management, Technology, Engineering, Software, Cer

In Q3 2020 ESI Group generated sales of 21.8m (-12.0% at current exchange rates), impacted by unfavorable exchange rate trends (-8.6% at constant exchange rate cer).

Key Points: 
  • In Q3 2020 ESI Group generated sales of 21.8m (-12.0% at current exchange rates), impacted by unfavorable exchange rate trends (-8.6% at constant exchange rate cer).
  • Q3 Licenses sales decreased to 17.0m (-7.8%, -3.9% cer) and represented 77.7% of total sales (vs. 74.2% in Q3 2019).
  • ESI Group's sales for the first 9-months of 2020 amounted to 102.6m (-9.3%, -9.0% cer) compared to the same period last year.
  • Present in more than 20 countries, and in major industrial sectors, ESI employs 1200 high level specialists around the world and reported 2019 sales of 146 million.

Government of Canada Announces Appointment of New Chief Executive Officer to the Canada Energy Regulator

Retrieved on: 
星期四, 七月 2, 2020
Alberta, Surname, Surnames, Cer, Silva, Gitane, Names

Today, the Government of Canada announced the Governor-in-Council appointment of Gitane De Silva as Chief Executive Officer (CEO) of the Canada Energy Regulator (CER), following an open and transparent competitive process that was launched in January 2020.

Key Points: 
  • Today, the Government of Canada announced the Governor-in-Council appointment of Gitane De Silva as Chief Executive Officer (CEO) of the Canada Energy Regulator (CER), following an open and transparent competitive process that was launched in January 2020.
  • Ms. De Silva is an experienced leader, having served in several senior executive roles within the governments of Canada and Alberta, including at Global Affairs Canada and as Alberta's Senior Representative to the United States.
  • "Ms. Gitane De Silva is a fine choice for CEO of the Canada Energy Regulator.
  • Her wealth of experience and knowledge will greatly benefit the CER as it continues to do great work for Canadians, our energy industries and the environment."

Introducing The World's Most Powerful Network For Driving Impact & Innovation In Education; edmaven launches at ASU+GSVX

Retrieved on: 
星期二, 四月 9, 2019
Foyer, Cer

edmaven draws on the nearly 3 decades of knowledge, connectivity, and credibility of founding partner the Center for Education Reform (CER).

Key Points: 
  • edmaven draws on the nearly 3 decades of knowledge, connectivity, and credibility of founding partner the Center for Education Reform (CER).
  • As a stand alone company, edmaven connects people and organizations to ideas and solutions in real-time, driving exponential impact in education across the United States and beyond.
  • Using proprietary intelligent technology currently in development, edmaven creates connections between people, organizations, ideas and resources working to accelerate education.
  • Information about edmaven will be available at the summit, at CER's booth #202 located in the Harbor Foyer on the 2nd Level.

Scientist.com and ZRx Outcomes Research Inc. Partner to Offer Online Access to Health Economic and Outcomes Research (HEOR)

Retrieved on: 
星期三, 三月 20, 2019
Articles, Health, Healthcare quality, Evidence-based practices, Comparative effectiveness research, Healthcare in the United States, Outcomes research, Scientist.com, Kevin Lustig, Systematic review, Cer, RWE

The Canadian-based company offers RWE research, systematic literature review, comparative effectiveness research (CER), decision modeling, dossier development and medical writing services.

Key Points: 
  • The Canadian-based company offers RWE research, systematic literature review, comparative effectiveness research (CER), decision modeling, dossier development and medical writing services.
  • "Many research organizations are now using HEOR and RWE datasets to optimize market access, reduce research costs and enable value-focused healthcare decisions," said Kevin Lustig, PhD, Scientist.com CEO and Founder.
  • By combining evidence from multiple sources, health economic outcomes research can provide an overview of comparative benefits and harms of various treatment options.
  • "Today's top research organizations are looking to access high-quality HEOR and RWE datasets to make healthcare decisions based on product behavior in a wide and heterogeneous population," said Vladimir Zah, DPhil, ZRx Outcomes Research CEO and Founder.